Viewing Study NCT00226057


Ignite Creation Date: 2025-12-24 @ 6:54 PM
Ignite Modification Date: 2025-12-25 @ 4:27 PM
Study NCT ID: NCT00226057
Status: COMPLETED
Last Update Posted: 2020-01-03
First Post: 2005-09-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Efalizumab for Moderate to Severe Atopic Dermatitis
Sponsor: Oregon Health and Science University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module